Giving aspirin and ibuprofen after myocardial infarction

British Medical Journal

Volumn 327, Issue 7427, 2003, Pages 1298-1299

  Kimmel, Stephen E ^a   Strom, Brian L ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Dept of Biostatist and Epidemiol ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; IBUPROFEN;

BLEEDING; DEMENTIA; DRUG EFFICACY; EDITORIAL; HEART INFARCTION; HUMAN; LONG TERM CARE; MORTALITY; PATIENT COMPLIANCE; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT; SIDE EFFECT; SMOKING;

EID: 0345527977     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.327.7427.1298     Document Type: Editorial

References (14)

1. Patrono C. Aspirin as an antiplatelet drug. N Engl J Med 1994;330:1287-93.
2. Lauer MS. Clinical practice. Aspirin for primary prevention of coronary events. N Engl J Med 2002;346:1468-74.
3. Catella-Lawson F, Reilly MP, Kapoor SC, Cucchiara AJ, DeMarco S, Tournier B, et al. Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. N Engl J Med 2001;345:1809-17.
4. Stiel D. Exploring the link between gastrointestinal complications and over-the-counter analgesics: current issues and considerations. Am J Ther 2000;7:91-8.
5. Wilcox CM, Shalek KA, Cotsonis G. Striking prevalence of over-the-counter nonsteroidal anti-inflammatory drug use in patients with upper gastrointestinal hemorrhage. Arch Intern Med 1994;154:42-6.
6. Curhan GC, Bullock AJ, Hankinson SE, Willett WC, Speizer FE, Stampfer MJ, Frequency of use of acetaminophen, nonsteroidal anti-inflammatory drugs, and aspirin in US women. Pharmacoepidemiol Drug Safety 2003;11:687-93.
7. Waeber B, Leonetti G, Kolloch R, McInnes GT. Compliance with aspirin or placebo in the hypertension optimal treatment (HOT) study. J Hypertens 1999;17:1041-5.
8. Glynn RJ, Buring JE, Manson JE, LaMotte F, Hennekens CH. Adherence to aspirin in the prevention of myocardial infarction. The physicians' health study. Arch Intern Med 1994;154:2649-57.
9. Kimmel SE, Berlin JA, Reilly M, Jaskowiak J, Kishel L, Strom BL. Nonselective nonaspirin nonsteroidal antiinflammatory medications are associated with reduced risk of myocardial infarction. J Am Coll Cardiol 2002;39:318A.
10. MacDonald TM, Wei L. Effect of ibuprofen on cardioprotective effect of aspirin. Lancet 2003;361:573-4.
11. Kurth T, Glynn RJ, Walker AM, Chan KA, Buring JE, Hennekens CH, et al. Inhibition of clinical benefits on first myocardial infarction by nonsteroidal antiinflammatory drugs. Circulation 2003;108:1191-5.
12. Curtis JP, Wang Y, Portnay EL, Masoudi FA, Havranek EP, Krumholz HM. Aspirin, ibuprofen, and mortality after myocardial infarction: retrospective cohort study. BMJ 2003;327:1322-3.
13. Benner JS, Glynn RJ, Mogun H, Neumann PJ, Weinstein MC, Avorn J. Long-term persistence in use of statin therapy in elderly patients. JAMA 2002;288:455-61.
14. Patel TN, Goldberg K. Ibuprofen does not appear to increase risk of myocardial infarction when used concurrently with aspirin. Circulation 2003;106:II 763-II 763 [abstract].